The use of topical Povidone Iodine (PVP-I) oropharyngeal and intranasal application during the current coronavirus pandemic as a potential measure to reduce viral transmissio
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/05/024962
- Lead Sponsor
- WIN MEDICARE PVTLTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients laboratory tested COVID-19 positive above 18 years of age +/- two days of admission
Exclusion Criteria
Known allergy to povidone iodine or iodine
thyroid disorders
pregnancy
patients on Lithium therapy
patients on respiratory distress / unconscious / on ventilator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method